Gastrointestinal endocrine tumors

Scandinavian Journal of Gastroenterology

Volumn 31, Issue SUPPL. 220, 1996, Pages 121-123

  Krejs, G J ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; PANCREAS ISLET CELL CARCINOMA; PANCREAS ISLET CELL TUMOR; PANCREAS TUMOR; REVIEW; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; ENDOCRINE TUMOR; GASTRINOMA; GASTROINTESTINAL TUMOR; GLUCAGONOMA; PRIORITY JOURNAL; SOMATOSTATINOMA;

ADENOMA, ISLET CELL; CARCINOMA, ISLET CELL; HUMANS; PANCREATIC NEOPLASMS;

ALPHA INTERFERON; CALCITONIN; FLUOROURACIL; GASTRIN; GLUCAGON; GROWTH HORMONE RELEASING FACTOR; OCTREOTIDE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

EID: 0029836625     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365529609094762     Document Type: Article

References (20)

1. Krejs GJ. Gastrointestinal endocrine tumors. Am J Med 1987; 82 Suppl 5B:l-3.
2. Zollinger RM, Ellison EH. Primary peptic ulceration of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955;142:709.
3. Rambaud J-C, Modigliani R, Emonts P, Matuchansky C, Vidon N, de Recherce M, et al. Fluid secretion in the duodenum and intestinal handling of water and electrolytes in Zollinger-Ellison syndrome. Dig Dis 1978;23:1089.
4. Guillausseau PJ, Guillausseau C,Villet R, Kaloustian E.Valleur P, Hautefeuille P, Lubetzki J. Les Glucagonomes. Aspects cliniques, biologiques, anatomopathologiques et therapeutiques. Gastroenterol Clin Biol 1982;6:1029.
5. Santangelo WC, Unger RH, Orci L, Dueno MI, Popma JJ, Krejs GJ. Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration. Pancreas 1986;1:464-9. (Pubitemid 18010849)
6. Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958; 25:374.
7. Bloom SR, Polak JM, Pearse AGE. Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet 1973;ii:4.
8. Krejs GJ, Fordtran JS, Bloom SR, Fahrenkrug J, Schaffalitzky de Muckadell OB, Fischer JE, et al. Effect of VIP infusion on water and ion transport in the human jejunum. Gastroenterology 1980;78:722-7. (Pubitemid 10103167)
9. Kane MG, O'Dorisio TM, Krejs GJ. Intravenous VIP infusion causes secretory diarrhea in man. N Engl J Med 1983; 309:1482-5.
10. Krejs GJ. VIPoma syndrome. Am J Med 1987; 82 Suppl 5B:37-48.
11. Krejs GJ, Orci L, Conlon JM, Ravazzola M, Davis GR, Raskin P, et al. Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med 1979;301:285-92. (Pubitemid 9244490)
12. Marcial MA, Pinkus GS, Skarin A, Hinrichs HR, Warhol MJ. Ampullary somatostatinoma: Psammomatous variant of gastrointestinal carcinoid tumor-an immunohistochemical and ultra-structural study. Report of a case and review of the literature. Am J Clin Pathol 1983;80:755.
13. Case 15-1989. Weekly clinicopathological conference. N Engl J Med 1989;320:996-1004.
14. ICrejs GJ. Non-insulin-secreting tumors of the gastroenteropan-creatic system. In: Foster DW, Wilson JD, editors. Williams Textbook of Endocrinology, 8th Ed. Philadelphia, London, Toronto: W. B. Saunders. 1992:1567-76.
15. Rivier J, Spiess J, Thorner M, Vale W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 1982;300:276-8. (Pubitemid 13234739)
16. Lipp, RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs GJ. Radiolabeled octreotide for the demonstation of somatostatin receptors in malignant lymphoma and lympha-denopathy. J Nucl Med 1995;36:13-8.
17. Rosen T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV, Yasuda K. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992;326:1721-6.
18. Arnold R, Neuhaus C, Benning R, Schwerk WB, Trautmann ME, Joseph K, Bruns C. Somatostatin analog Sandostatin and inhibition of tumor growth in patients with metatstatic endocrine gastroenteropancreatic tumors. World J Surg 1993;17:511-9. (Pubitemid 23228405)
19. Janson ET, Oberg K. Long-term management of the carcinoid syndrome. Acta Oncologica 1993;32:225-9.
20. Nold R, Frank M, Kajdan U, Trost U, Klose KJ, Arnold R. Kombinierte Behandlung metastasierter endokriner Tumoren des Gastrointestinaltrakts mit Octreotid und Interferon-Alpha. Z Gastroenterol 1994;32:193-7. (Pubitemid 24146571)